Human Pharmacokinetic Parameters of Orally Administered Δ9-Tetrahydrocannabinol Capsules Are Altered by Fed Versus Fasted Conditions and Sex Differences-Reference-Cited by-同舟云学术

Human Pharmacokinetic Parameters of Orally Administered Δ9-Tetrahydrocannabinol Capsules Are Altered by Fed Versus Fasted Conditions and Sex Differences

Published:2019-12-01 Issue:4 Volume:4 Page:255-264
ISSN:2578-5125
Container-title:Cannabis and Cannabinoid Research
language:en
Short-container-title:Cannabis and Cannabinoid Research

Author:

Lunn Stephanie¹,Diaz Patrick²,O'Hearn Shannon²,Cahill Shaina P.¹,Blake Alexia²,Narine Kelly¹,Dyck Jason R.B.¹³

Affiliation:

1. Aurora Cannabis, Inc.®, Leduc, Canada.

2. MedReleaf®, Markham, Canada.

3. Cardiovascular Research Centre, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

Link

https://www.liebertpub.com/doi/pdf/10.1089/can.2019.0037

Reference28 articles.

1. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science

2. 11-Hydroxy-Δ 9 -tetrahydrocannabinol: Pharmacology, Disposition, and Metabolism of a Major Metabolite of Marihuana in Man

3. Differential effects of delta-9-tetrahydrocannabinol and its 11-hydroxy metabolite on sodium current in neuroblastoma cells

4. Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes

5. Cannabinoids for Medical Use

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder;Schizophrenia Bulletin;2024-06-20

2. Sex differences in the acute effects of oral THC: a randomized, placebo-controlled, crossover human laboratory study;Psychopharmacology;2024-06-04

3. The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders;International Journal of Molecular Sciences;2024-05-25

4. Tolerability of High-Dose Oral Δ⁹-THC: Implications for Human Laboratory Study Design;Cannabis and Cannabinoid Research;2024-04-01

5. CYP2C9, CYP3A and CYP2C19 metabolize Δ9-tetrahydrocannabinol to multiple metabolites but metabolism is affected by human liver fatty acid binding protein (FABP1);Biochemical Pharmacology;2024-04